The Neutrophil-specific Antigen CD177 Is a Counter-receptor for Platelet Endothelial Cell Adhesion Molecule-1 (CD31)*

Human neutrophil-specific CD177 (NB1 and PRV-1) has been reported to be up-regulated in a number of inflammatory settings, including bacterial infection and granulocyte-colony-stimulating factor application. Little is known about its function. By flow cytometry and immunoprecipitation studies, we identified platelet endothelial cell adhesion molecule-1 (PECAM-1) as a binding partner of CD177. Real-time protein-protein analysis using surface plasmon resonance confirmed a cation-dependent, specific interaction between CD177 and the heterophilic domains of PECAM-1. Monoclonal antibodies against CD177 and against PECAM-1 domain 6 inhibited adhesion of U937 cells stably expressing CD177 to immobilized PECAM-1. Transendothelial migration of human neutrophils was also inhibited by these antibodies. Our findings provide direct evidence that neutrophil-specific CD177 is a heterophilic binding partner of PECAM-1. This interaction may constitute a new pathway that participates in neutrophil transmigration.

[1]  M. Segelmark,et al.  Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils , 2007, Journal of leukocyte biology.

[2]  G. Bein,et al.  Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections , 2006, Transfusion.

[3]  D. Arthur,et al.  The gene overexpressed in polycythemia rubra vera, PRV‐1, and the gene encoding a neutrophil alloantigen, NB1, are alleles of a single gene, CD177, in chromosome band 19q13.31 , 2006, Transfusion.

[4]  R. Bohle,et al.  Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. , 2006, Blood.

[5]  J. Bux,et al.  Sex‐dependent up regulation of CD177‐specific mRNA expression in cord blood due to different stimuli , 2006, Transfusion.

[6]  K. Preissner,et al.  The Junctional Adhesion Molecule-C Promotes Neutrophil Transendothelial Migration in Vitro and in Vivo* , 2004, Journal of Biological Chemistry.

[7]  F. Luscinskas,et al.  Coordinated Redistribution of Leukocyte LFA-1 and Endothelial Cell ICAM-1 Accompany Neutrophil Transmigration , 2004, The Journal of experimental medicine.

[8]  U. Sibelius,et al.  Neutrophil CD177 (NB1 gp, HNA‐2a) expression is increased in severe bacterial infections and polycythaemia vera , 2004, British journal of haematology.

[9]  D. Lefer,et al.  Leukocyte and endothelial adhesion molecule studies in knockout mice. , 2004, Current opinion in pharmacology.

[10]  C. Buckley,et al.  CD31 Regulates Direction and Rate of Neutrophil Migration over and under Endothelial Cells , 2003, Journal of Vascular Research.

[11]  A. Weyrich,et al.  Cell-cell interactions: leukocyte-endothelial interactions. , 2003, Current opinion in hematology.

[12]  D. Stroncek,et al.  Expression of human neutrophil antigen‐2a (NB1) is increased in pregnancy , 2003, Transfusion.

[13]  S. Nourshargh,et al.  PECAM-1 (CD31) Homophilic Interaction Up-Regulates α6β1 on Transmigrated Neutrophils In Vivo and Plays a Functional Role in the Ability of α6 Integrins to Mediate Leukocyte Migration through the Perivascular Basement Membrane , 2002, The Journal of experimental medicine.

[14]  K. Preissner,et al.  The Junctional Adhesion Molecule 3 (JAM-3) on Human Platelets is a Counterreceptor for the Leukocyte Integrin Mac-1 , 2002, The Journal of experimental medicine.

[15]  I. Richter,et al.  A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia. , 2002, Blood.

[16]  K. Preissner,et al.  Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation. , 2001, Biochemical Society transactions.

[17]  R P McEver,et al.  Adhesive Interactions of Leukocytes, Platelets, and the Vessel Wall during Hemostasis and Inflammation , 2001, Thrombosis and Haemostasis.

[18]  K. Kissel,et al.  Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immune neutropenias and transfusion reactions , 2001, European journal of immunology.

[19]  B. Engelhardt,et al.  PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. , 2000, Molecular biology of the cell.

[20]  S. Santoso,et al.  Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia. , 2000, Blood.

[21]  R. Colman,et al.  Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. , 2000, Blood.

[22]  S. Nourshargh,et al.  Divergent Effects of Platelet-Endothelial Cell Adhesion Molecule-1 and β3 Integrin Blockade on Leukocyte Transmigration In Vivo1 , 2000, The Journal of Immunology.

[23]  D. Stroncek,et al.  Variations in the expression of granulocyte antigen NB1 , 2000, Transfusion.

[24]  M. Lübbert,et al.  Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. , 2000, Blood.

[25]  Yoshiya Tanaka,et al.  Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of vβ3 Integrin and Enhances β1 Integrin-Mediated Adhesion of Eosinophils to Endothelial Cells , 1999 .

[26]  K. Preissner,et al.  Molecular Mechanisms of Zinc-Dependent Leukocyte Adhesion Involving the Urokinase Receptor and β2-Integrins , 1999 .

[27]  F. Ross,et al.  A Role for the αvβ3 Integrin in the Transmigration of Monocytes , 1998, The Journal of cell biology.

[28]  G. Visentin,et al.  Cell Surface Glycosaminoglycans Do Not Serve as Ligands for PECAM-1 , 1998, The Journal of Biological Chemistry.

[29]  U. Dianzani,et al.  Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. , 1998, Journal of immunology.

[30]  T. Plesner,et al.  Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPAR , 1997, Stem cells.

[31]  D. Jackson,et al.  Identification and characterization of functional cation coordination sites in platelet endothelial cell adhesion molecule-1. , 1997, Biochemistry.

[32]  F. Liao,et al.  Soluble Domain 1 of Platelet–Endothelial Cell Adhesion Molecule (PECAM) Is Sufficient to Block Transendothelial Migration In Vitro and In Vivo , 1997, The Journal of experimental medicine.

[33]  H. DeLisser,et al.  Individually Distinct Ig Homology Domains in PECAM-1 Regulate Homophilic Binding and Modulate Receptor Affinity (*) , 1996, The Journal of Biological Chemistry.

[34]  D. Stroncek,et al.  Analysis of the expression of NB1 antigen using two monoclonal antibodies , 1996, Transfusion.

[35]  F. Liao,et al.  Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1 , 1995, The Journal of experimental medicine.

[36]  C. Uherek,et al.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium , 1995, The Journal of cell biology.

[37]  H. DeLisser,et al.  Localization of multiple functional domains on human PECAM-1 (CD31) by monoclonal antibody epitope mapping. , 1995, Cell adhesion and communication.

[38]  W. Muller,et al.  Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). , 1995, Journal of immunology.

[39]  H. DeLisser,et al.  Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. , 1994, The Journal of biological chemistry.

[40]  W. Muller,et al.  Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo , 1994, The Journal of experimental medicine.

[41]  D. Stroncek,et al.  Neutrophil-specific antigen NB1 inhibits neutrophil-endothelial cell interactions. , 1994, The Journal of laboratory and clinical medicine.

[42]  H. DeLisser,et al.  Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties , 1994, The Journal of cell biology.

[43]  D. Phillips,et al.  PECAM-1 is required for transendothelial migration of leukocytes , 1993, The Journal of experimental medicine.

[44]  H. DeLisser,et al.  Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. , 1993, The Journal of biological chemistry.

[45]  H. DeLisser,et al.  A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31) , 1992, The Journal of experimental medicine.

[46]  L. Romer,et al.  EndoCAM: a novel endothelial cell-cell adhesion molecule , 1990, The Journal of cell biology.

[47]  D. Stroncek,et al.  Biochemical characterization of the neutrophil-specific antigen NB1. , 1990, Blood.

[48]  W. Muller,et al.  A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions , 1989, The Journal of experimental medicine.

[49]  P. Lalezari,et al.  NB1, a new neutrophil-specific antigen involved in the pathogenesis of neonatal neutropenia. , 1971, The Journal of clinical investigation.